Liu lab 2016/2017: Cas9-nickase fused to cytidine or adenine deaminase enables C→T (CBE) or A→G (ABE) single-base edits without DSB. Expands therapeutic CRISPR scope to point mutations.
Liu lab 2016/2017: Cas9-nickase fused to cytidine or adenine deaminase enables C→T (CBE) or A→G (ABE) single-base edits without DSB. Expands therapeutic CRISPR scope to point mutations.